Crinetics Pharmaceuticals...

NASDAQ: CRNX · Real-Time Price · USD
30.33
0.64 (2.16%)
At close: Aug 15, 2025, 1:20 PM

Crinetics Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-298.41M -214.53M -163.92M -107.64M
Depreciation & Amortization
2.79M 1.1M 983K 922K
Stock-Based Compensation
69.39M 40.94M 28.27M 17.35M
Other Working Capital
-5.91M -6.6M 7.62M -5.2M
Other Non-Cash Items
-11.37M 26.63M 850K -739K
Deferred Income Tax
n/a -28.48M n/a 422K
Change in Working Capital
11.63M 8.04M 18.61M 1.1M
Operating Cash Flow
-225.97M -166.31M -115.2M -88.59M
Capital Expenditures
-3.84M -4.69M -1.66M -436K
Cash Acquisitions
n/a 195.72M 34K 422K
Purchase of Investments
-1.16B -532.86M -329.82M -125.4M
Sales Maturities Of Investments
575.8M 337.13M 157.49M 69.36M
Other Investing Acitivies
14.93M -195.72M -34K -422K
Investing Cash Flow
-574.82M -200.41M -173.98M -56.48M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
40.39M 19.93M 4.72M 3.14M
Financial Cash Flow
1.01B 388.94M 121.96M 252.68M
Net Cash Flow
209.65M 22.22M -167.22M 107.61M
Free Cash Flow
-229.81M -171M -116.86M -89.02M